Skip to main content
Premium Trial:

Request an Annual Quote

Procter & Gamble to Use Eagle Genomics' Bioinformatics Platform for R&D

NEW YORK (GenomeWeb) – Eagle Genomics said today that Procter & Gamble has signed a four-year agreement with the company to deploy Eaglecore, its bioinformatics software platform, for use in its internal research and development activities.

Specially, P&G's global biotechnology and life science division will use Eaglecore in its efforts to develop new products, organize data, and integrate legacy and more recent data for analysis purposes. The cloud-based software, which launched last September, provides tools for capturing, annotating, and sharing data among other capabilities. As part of the deal, Eagle will provide additional data curation services.

This deal builds on an existing partnership involving Eagle's consultancy arm, which P&G has tapped to support past research efforts.

Financial and other terms of the licensing agreement were not disclosed.


The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.